
Guilherme Attizzani MD
Director, Valve and Structural Heart Disease Center, Harrington Heart and Vascular Institute, University Hospitals
Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-3800
Dr. Attizzani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Certifications & Licensure
- OH State Medical License 2014 - 2023
Clinical Trials
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2019 Jun 10
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Modified transcatheter aortic valve replacement: the pros and cons of removing the guidewire immediately after valve deployment.Brig Navreet Singh, Guilerme F Attizzani
The Journal of Invasive Cardiology. 2025-04-01 - Readmissions after next-day discharge following transcatheter aortic valve implantation.Rodrigo Bagur, Michael W A Chu, Conrad Kabali, Santiago Ordoñez, Ali S Husain
Eurointervention. 2024-12-16 - Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial.Didier Tchétché, Roxana Mehran, Daniel J Blackman, Ramzi F Khalil, Helge Möllmann
JAMA Cardiology. 2024-12-01
Journal Articles
- Focus on Coronary Physiology New Volumetric Analysis Method for Stent Expansion and Its Correlation with Final Fractional Flow Reserve and Clinical Outcome: An ILUMIEN...Sandeep M Patel, Matthew J Price, Michael R Jones, Guilherme F Attizzani, ScienceDirect
Authored Content
- Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement with a Self-Expandable ValveAugust 2020
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
Press Mentions
- Q&A: How Supra-Annular, Self-Expanding TAVR Valves Open up Options for Future InterventionsNovember 22nd, 2024
- TAVR: Favorable Hemodynamics with Evolut PROJune 20th, 2020
- University Hospitals Completes First Evolut™ PRO+ Case in the WorldJanuary 24th, 2020
- Join now to see all
Other Languages
- Spanish, Italian, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: